カテゴリー： GlobalInfoResearch, 世界, 部品/材料

滅菌乾燥粉末医薬品有効成分（API）の世界市場2022：化学合成薬、生物

◆英語タイトル：Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO5903 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：106 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

滅菌乾燥粉末医薬品有効成分（API）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の滅菌乾燥粉末医薬品有効成分（API）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

滅菌乾燥粉末医薬品有効成分（API）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・化学合成薬、生物

用途別セグメントは次のように区分されます。
・がん、糖尿病、循環器、筋骨格、その他

世界の滅菌乾燥粉末医薬品有効成分（API）市場の主要な市場プレーヤーは以下のとおりです。
・Dr. Reddy's Laboratories、Lonza Group、Sandoz International GmbH、Pfizer, Inc.、Aurobindo Pharma Limited、Corden Pharma GmbH、Sun Pharmaceutical Industries Ltd、Sanofi SA、Dalton Pharma Services、Teva Pharmaceutical Industries Ltd

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、滅菌乾燥粉末医薬品有効成分（API）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な滅菌乾燥粉末医薬品有効成分（API）メーカーの企業概要、2019年～2022年までの滅菌乾燥粉末医薬品有効成分（API）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な滅菌乾燥粉末医薬品有効成分（API）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別滅菌乾燥粉末医薬品有効成分（API）の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの滅菌乾燥粉末医薬品有効成分（API）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での滅菌乾燥粉末医薬品有効成分（API）市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および滅菌乾燥粉末医薬品有効成分（API）の産業チェーンを掲載しています。
・第13、14、15章では、滅菌乾燥粉末医薬品有効成分（API）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 滅菌乾燥粉末医薬品有効成分（API）の概要
- 種類別分析（2017年vs2021年vs2028年）：化学合成薬、生物
- 用途別分析（2017年vs2021年vs2028年）：がん、糖尿病、循環器、筋骨格、その他
- 世界の滅菌乾燥粉末医薬品有効成分（API）市場規模・予測
- 世界の滅菌乾燥粉末医薬品有効成分（API）生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Dr. Reddy's Laboratories、Lonza Group、Sandoz International GmbH、Pfizer, Inc.、Aurobindo Pharma Limited、Corden Pharma GmbH、Sun Pharmaceutical Industries Ltd、Sanofi SA、Dalton Pharma Services、Teva Pharmaceutical Industries Ltd
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：化学合成薬、生物
・用途別分析2017年-2028年：がん、糖尿病、循環器、筋骨格、その他
・滅菌乾燥粉末医薬品有効成分（API）の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・滅菌乾燥粉末医薬品有効成分（API）のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・滅菌乾燥粉末医薬品有効成分（API）のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・滅菌乾燥粉末医薬品有効成分（API）の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・滅菌乾燥粉末医薬品有効成分（API）の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Sterile Dry Powder Active Pharmaceutical Ingredient (API) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Sterile Dry Powder Active Pharmaceutical Ingredient (API) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Oncology accounting for % of the Sterile Dry Powder Active Pharmaceutical Ingredient (API) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Chemosynthesis Drug segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Sterile Dry Powder Active Pharmaceutical Ingredient (API) include Dr. Reddy’s Laboratories, Lonza Group, Sandoz International GmbH, Pfizer, Inc., and Aurobindo Pharma Limited, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Sterile Dry Powder Active Pharmaceutical Ingredient (API) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemosynthesis Drug
Biological
Market segment by Application can be divided into
Oncology
Anti-Diabetic
Cardiovascular
Musculoskeletal
Others
The key market players for global Sterile Dry Powder Active Pharmaceutical Ingredient (API) market are listed below:
Dr. Reddy’s Laboratories
Lonza Group
Sandoz International GmbH
Pfizer, Inc.
Aurobindo Pharma Limited
Corden Pharma GmbH
Sun Pharmaceutical Industries Ltd
Sanofi SA
Dalton Pharma Services
Teva Pharmaceutical Industries Ltd
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sterile Dry Powder Active Pharmaceutical Ingredient (API) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sterile Dry Powder Active Pharmaceutical Ingredient (API), with price, sales, revenue and global market share of Sterile Dry Powder Active Pharmaceutical Ingredient (API) from 2019 to 2022.
Chapter 3, the Sterile Dry Powder Active Pharmaceutical Ingredient (API) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sterile Dry Powder Active Pharmaceutical Ingredient (API) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sterile Dry Powder Active Pharmaceutical Ingredient (API) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sterile Dry Powder Active Pharmaceutical Ingredient (API).
Chapter 13, 14, and 15, to describe Sterile Dry Powder Active Pharmaceutical Ingredient (API) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Sterile Dry Powder Active Pharmaceutical Ingredient (API) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Chemosynthesis Drug
1.2.3 Biological
1.3 Market Analysis by Application
1.3.1 Overview: Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Anti-Diabetic
1.3.4 Cardiovascular
1.3.5 Musculoskeletal
1.3.6 Others
1.4 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Size & Forecast
1.4.1 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales in Volume (2017-2028)
1.4.3 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Price (2017-2028)
1.5 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Production Capacity Analysis
1.5.1 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Total Production Capacity (2017-2028)
1.5.2 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Drivers
1.6.2 Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Restraints
1.6.3 Sterile Dry Powder Active Pharmaceutical Ingredient (API) Trends Analysis
2 Manufacturers Profiles
2.1 Dr. Reddy’s Laboratories
2.1.1 Dr. Reddy’s Laboratories Details
2.1.2 Dr. Reddy’s Laboratories Major Business
2.1.3 Dr. Reddy’s Laboratories Sterile Dry Powder Active Pharmaceutical Ingredient (API) Product and Services
2.1.4 Dr. Reddy’s Laboratories Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Lonza Group
2.2.1 Lonza Group Details
2.2.2 Lonza Group Major Business
2.2.3 Lonza Group Sterile Dry Powder Active Pharmaceutical Ingredient (API) Product and Services
2.2.4 Lonza Group Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sandoz International GmbH
2.3.1 Sandoz International GmbH Details
2.3.2 Sandoz International GmbH Major Business
2.3.3 Sandoz International GmbH Sterile Dry Powder Active Pharmaceutical Ingredient (API) Product and Services
2.3.4 Sandoz International GmbH Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer, Inc.
2.4.1 Pfizer, Inc. Details
2.4.2 Pfizer, Inc. Major Business
2.4.3 Pfizer, Inc. Sterile Dry Powder Active Pharmaceutical Ingredient (API) Product and Services
2.4.4 Pfizer, Inc. Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Aurobindo Pharma Limited
2.5.1 Aurobindo Pharma Limited Details
2.5.2 Aurobindo Pharma Limited Major Business
2.5.3 Aurobindo Pharma Limited Sterile Dry Powder Active Pharmaceutical Ingredient (API) Product and Services
2.5.4 Aurobindo Pharma Limited Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Corden Pharma GmbH
2.6.1 Corden Pharma GmbH Details
2.6.2 Corden Pharma GmbH Major Business
2.6.3 Corden Pharma GmbH Sterile Dry Powder Active Pharmaceutical Ingredient (API) Product and Services
2.6.4 Corden Pharma GmbH Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sun Pharmaceutical Industries Ltd
2.7.1 Sun Pharmaceutical Industries Ltd Details
2.7.2 Sun Pharmaceutical Industries Ltd Major Business
2.7.3 Sun Pharmaceutical Industries Ltd Sterile Dry Powder Active Pharmaceutical Ingredient (API) Product and Services
2.7.4 Sun Pharmaceutical Industries Ltd Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sanofi SA
2.8.1 Sanofi SA Details
2.8.2 Sanofi SA Major Business
2.8.3 Sanofi SA Sterile Dry Powder Active Pharmaceutical Ingredient (API) Product and Services
2.8.4 Sanofi SA Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Dalton Pharma Services
2.9.1 Dalton Pharma Services Details
2.9.2 Dalton Pharma Services Major Business
2.9.3 Dalton Pharma Services Sterile Dry Powder Active Pharmaceutical Ingredient (API) Product and Services
2.9.4 Dalton Pharma Services Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva Pharmaceutical Industries Ltd
2.10.1 Teva Pharmaceutical Industries Ltd Details
2.10.2 Teva Pharmaceutical Industries Ltd Major Business
2.10.3 Teva Pharmaceutical Industries Ltd Sterile Dry Powder Active Pharmaceutical Ingredient (API) Product and Services
2.10.4 Teva Pharmaceutical Industries Ltd Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Sterile Dry Powder Active Pharmaceutical Ingredient (API) Breakdown Data by Manufacturer
3.1 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Sterile Dry Powder Active Pharmaceutical Ingredient (API)
3.4 Market Concentration Rate
3.4.1 Top 3 Sterile Dry Powder Active Pharmaceutical Ingredient (API) Manufacturer Market Share in 2021
3.4.2 Top 6 Sterile Dry Powder Active Pharmaceutical Ingredient (API) Manufacturer Market Share in 2021
3.5 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Sterile Dry Powder Active Pharmaceutical Ingredient (API) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Size by Region
4.1.1 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales in Volume by Region (2017-2028)
4.1.2 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue by Region (2017-2028)
4.2 North America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue (2017-2028)
4.3 Europe Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue (2017-2028)
4.4 Asia-Pacific Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue (2017-2028)
4.5 South America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue (2017-2028)
4.6 Middle East and Africa Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales in Volume by Type (2017-2028)
5.2 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue by Type (2017-2028)
5.3 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales in Volume by Application (2017-2028)
6.2 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue by Application (2017-2028)
6.3 Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
7.2 North America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
7.3 North America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Size by Country
7.3.1 North America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2017-2028)
7.3.2 North America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
8.2 Europe Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
8.3 Europe Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Size by Country
8.3.1 Europe Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2017-2028)
8.3.2 Europe Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
9.2 Asia-Pacific Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
9.3 Asia-Pacific Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Size by Region
9.3.1 Asia-Pacific Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
10.2 South America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
10.3 South America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Size by Country
10.3.1 South America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2017-2028)
10.3.2 South America Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales by Type (2017-2028)
11.2 Middle East & Africa Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales by Application (2017-2028)
11.3 Middle East & Africa Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Size by Country
11.3.1 Middle East & Africa Sterile Dry Powder Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Sterile Dry Powder Active Pharmaceutical Ingredient (API) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Sterile Dry Powder Active Pharmaceutical Ingredient (API) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Sterile Dry Powder Active Pharmaceutical Ingredient (API)
12.3 Sterile Dry Powder Active Pharmaceutical Ingredient (API) Production Process
12.4 Sterile Dry Powder Active Pharmaceutical Ingredient (API) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Sterile Dry Powder Active Pharmaceutical Ingredient (API) Typical Distributors
13.3 Sterile Dry Powder Active Pharmaceutical Ingredient (API) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 滅菌乾燥粉末医薬品有効成分（API）の世界市場2022：化学合成薬、生物(Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

滅菌乾燥粉末医薬品有効成分（API）の世界市場2022：化学合成薬、生物

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp